Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.040
-0.040 (-1.30%)
At close: Nov 20, 2026, 4:00 PM EST
3.100
+0.060 (1.97%)
After-hours: Nov 20, 2026, 7:56 PM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.12 billion as of November 20, 2026. Its market cap has increased by 24.03% in one year.
Market Cap
1.12B
Enterprise Value
439.49M
1-Year Change
24.03%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $1.12B, a decrease of -1.52%. That is a compound annual growth rate of -0.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.11B | 10.64% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 2.16B |
| BioCryst Pharmaceuticals | 1.88B |
| Trulieve Cannabis | 1.80B |
| Eton Pharmaceuticals | 1.77B |
| Alvotech | 1.53B |
| ANI Pharmaceuticals | 1.46B |
| Phibro Animal Health | 1.38B |
| Harrow | 1.21B |